Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quanterix Corp

6.30
+0.18002.94%
Volume:711.95K
Turnover:4.38M
Market Cap:244.63M
PE:-5.07
High:6.30
Open:6.10
Low:5.98
Close:6.12
Loading ...

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

THOMSON REUTERS
·
17 Apr

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Business Wire
·
17 Apr

Kent Lake Comments on Quanterix's Bridge Financing for Akoya

THOMSON REUTERS
·
07 Apr

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

Business Wire
·
07 Apr

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Business Wire
·
01 Apr

BRIEF-Quanterix Corp - On March 24, Appointed William P. Donnelly As Chairman - SEC Filing

Reuters
·
29 Mar

Quanterix Corp - on March 24, Appointed William P. Donnelly as Chairman - SEC Filing

THOMSON REUTERS
·
29 Mar

BUZZ-Impact of NIH job cuts "better than feared" for life sciences firms, Leerink says

Reuters
·
27 Mar

Quanterix Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
25 Mar

Scotiabank Reaffirms Their Buy Rating on Quanterix (QTRX)

TIPRANKS
·
25 Mar

Quanterix Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
19 Mar

Q4 2024 Quanterix Corp Earnings Call

Thomson Reuters StreetEvents
·
18 Mar

Quanterix Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
18 Mar

U.S. RESEARCH ROUNDUP-American Electric Power, Block, Lenz Therapeutics

Reuters
·
18 Mar

Quanterix Corp : Canaccord Genuity Cuts Target Price to $15 From $20

THOMSON REUTERS
·
18 Mar

Quanterix Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Mar

Quanterix Q4 Net Loss Widens, Revenue Rises, 2025 Revenue Outlook Set

MT Newswires Live
·
18 Mar

Quanterix Q4 2024 GAAP EPS $(0.30) Misses $(0.25) Estimate, Sales $35.200M Beat $34.437M Estimate

Benzinga
·
18 Mar

BRIEF-Quanterix Q4 Net Income USD -11.625 Million

Reuters
·
18 Mar

Akoya Biosciences Inc Q4 Shr View $-0.16, REV View $21.3 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
18 Mar